LC
APLT

Lindbrook Capital’s Applied Therapeutics APLT Stock Holding History

Lindbrook Capital’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-103
Closed -$876 – 2779
2024
Q3 		$876 Sell
103
-100
-49% -$589 ﹤0.01% 2532
2024
Q2 		$948 Buy
+203
New +$961 ﹤0.01% 2500

Other funds holding APLT

VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Lindbrook Capital's APLT Position: Q4 2024 in Review

Lindbrook Capital sold out of Applied Therapeutics (APLT) in Q4 2024, closing a stake of 103 shares — an estimated $876 sold.

Lindbrook Capital first reported a position in APLT in Q2 2024 and held it in 2 quarters. The position peaked at $948 in Q2 2024. 119 funds tracked by Wall St. Rank hold APLT as of Q4 2024.

  • Lindbrook Capital reported no remaining Applied Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Lindbrook Capital sold 103 Applied Therapeutics shares in Q4 2024, an estimated $876.
  • Lindbrook Capital first reported a position in Applied Therapeutics in Q2 2024 and held it in 2 quarters.
  • Lindbrook Capital's Applied Therapeutics position peaked at $948 in Q2 2024.
  • 119 funds tracked by Wall St. Rank held Applied Therapeutics as of Q4 2024.

Based on Lindbrook Capital's 13F filing for Q4 2024, filed 6 Feb 2025.